As part of a restructuring plan that has cost many employees of Advanced Tissue Sciences Inc. their jobs, the company intends to sell its interest in its Dermagraft joint venture to partner Smith & Nephew. (BioWorld Today)
As part of a restructuring plan that has cost many employees of Advanced Tissue Sciences Inc. their jobs, the company intends to sell its interest in its Dermagraft joint venture to partner Smith & Nephew. (BioWorld Today)
WASHINGTON - The series of missteps surrounding the application process for ImClone Systems Inc.'s cancer drug, Erbitux, has forced the FDA to rethink some of its procedures. (BioWorld Today)
WASHINGTON - The series of missteps surrounding the application process for ImClone Systems Inc.'s cancer drug, Erbitux, has forced the FDA to rethink some of its procedures. (BioWorld Today)
